RXRX - Recursion Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

RXRX is currently covered by 3 analysts with an average price target of $6.5. This is a potential upside of $4.05 (165.31%) from yesterday's end of day stock price of $2.45.

Recursion Pharmaceuticals's activity chart (see below) currently has 94 price targets and 73 ratings on display. The stock rating distribution of RXRX is 60% BUY and 40% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 56.54% of the time, taking 45 days on average.

Highest price target for RXRX is $8, Lowest price target is $5.5, average price target is $6.5.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 19-Oct-2026. First documented stock forecast 11-May-2021.

Currently out of the existing stock ratings of RXRX, 3 are a BUY (60%), 2 are a HOLD (40%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Mar-2023

$8

$5.55 (226.53%)

$8

1 months 3 days ago
(19-Oct-2026)

2/29 (6.9%)

$4.39 (121.61%)

71

Hold Since 18-Aug-2025

$5.5

$3.05 (124.49%)

$5

6 months 8 days ago
(14-May-2026)

1/3 (33.33%)

$2.46 (80.92%)

2

Hold Since 26-Feb-2026

$6

$3.55 (144.90%)

$10

8 months 27 days ago
(26-Feb-2026)

2/3 (66.67%)

$2.23 (59.15%)

73

Hold Since 03-Sep-2024

$5

$8

1 years 4 months 19 days ago
(03-Jul-2025)

3/5 (60%)

$-0.27 (-5.12%)

65

Hold Since 25-Oct-2022

$6

$8

1 years 8 months 20 days ago
(02-Mar-2025)

6/8 (75%)

$-1.51 (-20.11%)

59

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RXRX (Recursion Pharmaceuticals) average time for price targets to be met?

On average it took 45 days for the stock forecasts to be reached, with an average price target met ratio of 56.54%.

Which analyst most recently updated their price target on RXRX (Recursion Pharmaceuticals)?

Gil Blum

Which analyst has the most public recommendations on RXRX (Recursion Pharmaceuticals)?

Gil Blum works at NEEDHAM and has 38 price targets and 35 ratings on RXRX

Which analyst is the currently most bullish on RXRX (Recursion Pharmaceuticals)?

Gal Munda with the highest potential upside of $32.55

Which analyst is the currently most reserved on RXRX (Recursion Pharmaceuticals)?

Vikram Purohit with the lowest potential downside of $2.55
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?